Envoy Medical company info

What does Envoy Medical do?
Envoy Medical (NASDAQ:COCH) is a public hearing health company focused on innovative technologies for various hearing loss levels. They develop and market implantable devices to address hearing challenges. Their flagship product, the Esteem® active middle ear implant, has been available in the US since 2010. They're also developing the Acclaim® cochlear implant, currently under investigation. Envoy Medical prioritizes improving patient access, usability, and quality of life through their advanced hearing solutions.
Envoy Medical company media
Company Snapshot

Is Envoy Medical a public or private company?

key
Ownership
Public

How many people does Envoy Medical employ?

people
Employees
34

What sector is Envoy Medical in?

pie chart
Sector
Health Care

Where is the head office for Envoy Medical?

location pin
Head Office
Minnesota, United States

What year was Envoy Medical founded?

founded flag
Year Founded
1995
What does Envoy Medical specialise in?
/Special Acquisition /Corporate Mergers /Equity Financing /Investment Services /Asset Management /Business Integration

What are the products and/or services of Envoy Medical?

Overview of Envoy Medical offerings
Esteem, a fully implantable hearing device designed to alleviate moderate to severe sensorineural hearing loss.
Hearing aids and related accessories tailored to improve the quality of life for individuals with hearing impairments.
Research and development in advanced hearing technologies aiming to offer innovative solutions for hearing loss.
Collaboration with medical professionals to ensure the delivery of high-quality hearing care and devices.
Educational initiatives and resources to raise awareness about hearing loss and the solutions available.
Customer support services to assist users in maximizing the benefits of their hearing devices.

Who is in the executive team of Envoy Medical?

Envoy Medical leadership team
  • Mr. Brent T. Lucas Esq.
    Mr. Brent T. Lucas Esq.
    CEO & Director
  • Mr. David R. Wells
    Mr. David R. Wells
    Chief Financial Officer